Literature DB >> 16893317

Clinic-based treatment for opioid dependence: a qualitative inquiry.

Suzanne McMurphy1, Judy Shea, Julia Switzer, Barbara J Turner.   

Abstract

OBJECTIVES: To identify barriers and facilitators to treatment of opioid dependence in primary care clinics.
METHODS: In-depth interviews with 27 New York State clinic directors.
RESULTS: Stigmatizing attitudes emerged as a major barrier. Respondents often viewed opioid-dependent persons as manipulative, demanding, and disruptive. Commonly cited facilitators were physician training, increased office staffing, and greater mental health, social services, and addictions support.
CONCLUSIONS: Our study reveals attitudinal barriers to address and supportive factors to promote in order to increase the limited availability of office-based treatment of opioid dependence in the United States compared with other countries.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16893317     DOI: 10.5555/ajhb.2006.30.5.544

Source DB:  PubMed          Journal:  Am J Health Behav        ISSN: 1087-3244


  8 in total

1.  Pathways of Substance Users Linking (Or Not) With Treatment.

Authors:  Cristina Redko; Richard C Rapp; Robert G Carlson
Journal:  J Drug Issues       Date:  2007

2.  A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.

Authors:  Katharine Cioe; Breanne E Biondi; Rebecca Easly; Amanda Simard; Xiao Zheng; Sandra A Springer
Journal:  J Subst Abuse Treat       Date:  2020-09-22

3.  Integrating buprenorphine treatment into office-based practice: a qualitative study.

Authors:  Declan T Barry; Kevin S Irwin; Emlyn S Jones; William C Becker; Jeanette M Tetrault; Lynn E Sullivan; Helena Hansen; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin
Journal:  J Gen Intern Med       Date:  2008-12-17       Impact factor: 5.128

4.  A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.

Authors:  Rebecca L Haffajee; Barbara Andraka-Christou; Jeremy Attermann; Anna Cupito; Jessica Buche; Angela J Beck
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-09-14

5.  Barriers and facilitators to office-based opioid agonist therapy prescribing and effective interventions to increase provider prescribing: protocol for a systematic review.

Authors:  Lara L Nixon; Jazmin C Marlinga; K Alix Hayden; Kelly J Mrklas
Journal:  Syst Rev       Date:  2019-07-25

6.  Stigma as a fundamental hindrance to the United States opioid overdose crisis response.

Authors:  Alexander C Tsai; Mathew V Kiang; Michael L Barnett; Leo Beletsky; Katherine M Keyes; Emma E McGinty; Laramie R Smith; Steffanie A Strathdee; Sarah E Wakeman; Atheendar S Venkataramani
Journal:  PLoS Med       Date:  2019-11-26       Impact factor: 11.069

7.  Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics.

Authors:  Ariadna Forray; Amanda Mele; Nancy Byatt; Amalia Londono Tobon; Kathryn Gilstad-Hayden; Karen Hunkle; Suyeon Hong; Heather Lipkind; David A Fiellin; Katherine Callaghan; Kimberly A Yonkers
Journal:  PLoS One       Date:  2022-01-13       Impact factor: 3.240

8.  Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: Implications for treatment systems and potential impact on client outcomes.

Authors:  Nicola R Jones; Suzanne Nielsen; Michael Farrell; Robert Ali; Anthony Gill; Sarah Larney; Louisa Degenhardt
Journal:  Drug Alcohol Depend       Date:  2020-12-19       Impact factor: 4.492

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.